avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2e3
|
ENSMUSG00000032292.2 | nuclear receptor subfamily 2, group E, member 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr2e3 | mm10_v2_chr9_-_59950068_59950122 | 0.49 | 2.4e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
1.5 | 6.0 | GO:0035524 | proline transmembrane transport(GO:0035524) glycine import(GO:0036233) |
1.2 | 3.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.9 | 6.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.9 | 2.7 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
0.8 | 6.3 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.8 | 2.4 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.6 | 3.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.5 | 1.9 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.5 | 1.4 | GO:2001076 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.5 | 5.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.4 | 1.3 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 7.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 2.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 2.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 3.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 1.2 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.3 | 1.3 | GO:0061153 | negative regulation of interleukin-13 production(GO:0032696) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 1.3 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 1.9 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.3 | 0.9 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 2.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.9 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 1.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.3 | 1.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.3 | 1.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 1.5 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) leading edge cell differentiation(GO:0035026) |
0.2 | 0.9 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 1.2 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.2 | 1.6 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.2 | 0.6 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 1.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.2 | 0.6 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.2 | 1.5 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.5 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.2 | 2.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 2.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 1.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 1.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 4.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.3 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.3 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 3.5 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.5 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.1 | 4.9 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 1.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) response to glycoprotein(GO:1904587) |
0.0 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 2.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 1.0 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.5 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.0 | 1.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 1.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.8 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 0.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.2 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) tachykinin receptor signaling pathway(GO:0007217) operant conditioning(GO:0035106) positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.8 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.3 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 1.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 2.2 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.8 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 3.1 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.0 | 0.7 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 1.1 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.5 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
1.1 | 3.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 1.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 2.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 1.2 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 1.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 1.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 7.9 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 2.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 2.3 | GO:0005859 | muscle myosin complex(GO:0005859) myosin filament(GO:0032982) |
0.1 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 4.7 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.2 | GO:0097059 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 2.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 2.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.0 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) integrin alphav-beta6 complex(GO:0034685) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 2.6 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 17.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 6.3 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 7.8 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 1.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 1.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.4 | GO:0005884 | actin filament(GO:0005884) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.4 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
2.0 | 6.0 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
1.2 | 7.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.1 | 9.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) RAGE receptor binding(GO:0050786) |
0.9 | 3.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.7 | 3.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.6 | 1.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 2.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 1.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 2.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 4.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 6.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 5.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 1.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.2 | 1.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 2.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 2.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 1.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 1.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 1.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.6 | GO:0044020 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 4.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 3.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 2.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 1.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.5 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 0.3 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 2.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 6.3 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 3.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 4.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 1.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 1.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 1.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 1.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 1.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 3.4 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 1.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 1.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 1.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 1.0 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 10.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 5.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 7.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 7.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 3.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 4.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 3.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 3.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 2.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 4.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 2.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 3.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 2.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 6.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 6.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 5.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 5.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 5.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 2.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 1.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.3 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |